Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). / Parveen, Saaima; Zareini, Bochra; Arulmurugananthavadivel, Anojhaan; Kistorp, Caroline; Faber, Jens; Køber, Lars; Hassager, Christian; Sørensen, Tor Biering; Andersson, Charlotte; Zahir, Deewa; Iversen, Kasper; Wolsk, Emil; Gislason, Gunnar; Gaborit, Freja; Schou, Morten.

In: BMC Geriatrics, Vol. 22, 230, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Parveen, S, Zareini, B, Arulmurugananthavadivel, A, Kistorp, C, Faber, J, Køber, L, Hassager, C, Sørensen, TB, Andersson, C, Zahir, D, Iversen, K, Wolsk, E, Gislason, G, Gaborit, F & Schou, M 2022, 'Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)', BMC Geriatrics, vol. 22, 230. https://doi.org/10.1186/s12877-022-02875-1

APA

Parveen, S., Zareini, B., Arulmurugananthavadivel, A., Kistorp, C., Faber, J., Køber, L., Hassager, C., Sørensen, T. B., Andersson, C., Zahir, D., Iversen, K., Wolsk, E., Gislason, G., Gaborit, F., & Schou, M. (2022). Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). BMC Geriatrics, 22, [230]. https://doi.org/10.1186/s12877-022-02875-1

Vancouver

Parveen S, Zareini B, Arulmurugananthavadivel A, Kistorp C, Faber J, Køber L et al. Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). BMC Geriatrics. 2022;22. 230. https://doi.org/10.1186/s12877-022-02875-1

Author

Parveen, Saaima ; Zareini, Bochra ; Arulmurugananthavadivel, Anojhaan ; Kistorp, Caroline ; Faber, Jens ; Køber, Lars ; Hassager, Christian ; Sørensen, Tor Biering ; Andersson, Charlotte ; Zahir, Deewa ; Iversen, Kasper ; Wolsk, Emil ; Gislason, Gunnar ; Gaborit, Freja ; Schou, Morten. / Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). In: BMC Geriatrics. 2022 ; Vol. 22.

Bibtex

@article{2f3cc0f91604458a99cd5fe3a4fa120a,
title = "Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)",
abstract = "Background: Early stages of heart failure (HF) are associated with an increased risk of hospitalization and increased mortality, however the course of progression and the impact of non-cardiovascular comorbidities on adverse events in elderly high-risk patients are unknown. Aim: To examine the risk of future cardiovascular (CV) and non-CV events in early stages of HF in a cohort of elderly patients (age ≥ 60 with ≥ 1 risk factor for HF and without known or clinically suspected HF). Methods: A total of 400 patients (American Heart Association HF stage A: N = 177; stage B: N = 150; stage C: N = 73) from the Copenhagen Heart Failure Risk Study were identified and followed for the main composite outcome of a HF hospitalization (HFH), ischemic heart disease (IHD), stroke, and all-cause death, recorded within the Danish nationwide registries. Non-CV hospitalization was a secondary outcome. Absolute risk was calculated by the Aalen-Johansen estimator. Results: The median follow-up time was 3.3 years, total number of events were 83, and the 3-year risk (95% confidence interval) of the main outcome was 12.8% (7.8–17.9), 22.8% (16.1–29.6) and 31.8% (21.0–42.6) for patients with stage A, B, and C, respectively. 1.1% (0.0–2.7), 3.4% (1.0–6.3) and 10.0% (2.8–16.3) experienced HFH as their first event, whereas 37.3% (30.2–44.4), 49.7% (41.6–57.8) and 54.8% (43.4–66.2) were admitted for non-CV causes as their first event. Conclusion: The risk of HFH, IHD, stroke and all-cause death increased with severity of HF stage, and 10% of patients with undiagnosed HF stage C were admitted for HF within 3 years. However, the risk of non-CV hospitalizations was greater compared to the risk of experiencing HFH.",
keywords = "All-cause mortality, Comorbidity, Heart failure, Heart failure stages, Population attributable risk",
author = "Saaima Parveen and Bochra Zareini and Anojhaan Arulmurugananthavadivel and Caroline Kistorp and Jens Faber and Lars K{\o}ber and Christian Hassager and S{\o}rensen, {Tor Biering} and Charlotte Andersson and Deewa Zahir and Kasper Iversen and Emil Wolsk and Gunnar Gislason and Freja Gaborit and Morten Schou",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
doi = "10.1186/s12877-022-02875-1",
language = "English",
volume = "22",
journal = "B M C Geriatrics",
issn = "1471-2318",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)

AU - Parveen, Saaima

AU - Zareini, Bochra

AU - Arulmurugananthavadivel, Anojhaan

AU - Kistorp, Caroline

AU - Faber, Jens

AU - Køber, Lars

AU - Hassager, Christian

AU - Sørensen, Tor Biering

AU - Andersson, Charlotte

AU - Zahir, Deewa

AU - Iversen, Kasper

AU - Wolsk, Emil

AU - Gislason, Gunnar

AU - Gaborit, Freja

AU - Schou, Morten

N1 - Publisher Copyright: © 2022, The Author(s).

PY - 2022

Y1 - 2022

N2 - Background: Early stages of heart failure (HF) are associated with an increased risk of hospitalization and increased mortality, however the course of progression and the impact of non-cardiovascular comorbidities on adverse events in elderly high-risk patients are unknown. Aim: To examine the risk of future cardiovascular (CV) and non-CV events in early stages of HF in a cohort of elderly patients (age ≥ 60 with ≥ 1 risk factor for HF and without known or clinically suspected HF). Methods: A total of 400 patients (American Heart Association HF stage A: N = 177; stage B: N = 150; stage C: N = 73) from the Copenhagen Heart Failure Risk Study were identified and followed for the main composite outcome of a HF hospitalization (HFH), ischemic heart disease (IHD), stroke, and all-cause death, recorded within the Danish nationwide registries. Non-CV hospitalization was a secondary outcome. Absolute risk was calculated by the Aalen-Johansen estimator. Results: The median follow-up time was 3.3 years, total number of events were 83, and the 3-year risk (95% confidence interval) of the main outcome was 12.8% (7.8–17.9), 22.8% (16.1–29.6) and 31.8% (21.0–42.6) for patients with stage A, B, and C, respectively. 1.1% (0.0–2.7), 3.4% (1.0–6.3) and 10.0% (2.8–16.3) experienced HFH as their first event, whereas 37.3% (30.2–44.4), 49.7% (41.6–57.8) and 54.8% (43.4–66.2) were admitted for non-CV causes as their first event. Conclusion: The risk of HFH, IHD, stroke and all-cause death increased with severity of HF stage, and 10% of patients with undiagnosed HF stage C were admitted for HF within 3 years. However, the risk of non-CV hospitalizations was greater compared to the risk of experiencing HFH.

AB - Background: Early stages of heart failure (HF) are associated with an increased risk of hospitalization and increased mortality, however the course of progression and the impact of non-cardiovascular comorbidities on adverse events in elderly high-risk patients are unknown. Aim: To examine the risk of future cardiovascular (CV) and non-CV events in early stages of HF in a cohort of elderly patients (age ≥ 60 with ≥ 1 risk factor for HF and without known or clinically suspected HF). Methods: A total of 400 patients (American Heart Association HF stage A: N = 177; stage B: N = 150; stage C: N = 73) from the Copenhagen Heart Failure Risk Study were identified and followed for the main composite outcome of a HF hospitalization (HFH), ischemic heart disease (IHD), stroke, and all-cause death, recorded within the Danish nationwide registries. Non-CV hospitalization was a secondary outcome. Absolute risk was calculated by the Aalen-Johansen estimator. Results: The median follow-up time was 3.3 years, total number of events were 83, and the 3-year risk (95% confidence interval) of the main outcome was 12.8% (7.8–17.9), 22.8% (16.1–29.6) and 31.8% (21.0–42.6) for patients with stage A, B, and C, respectively. 1.1% (0.0–2.7), 3.4% (1.0–6.3) and 10.0% (2.8–16.3) experienced HFH as their first event, whereas 37.3% (30.2–44.4), 49.7% (41.6–57.8) and 54.8% (43.4–66.2) were admitted for non-CV causes as their first event. Conclusion: The risk of HFH, IHD, stroke and all-cause death increased with severity of HF stage, and 10% of patients with undiagnosed HF stage C were admitted for HF within 3 years. However, the risk of non-CV hospitalizations was greater compared to the risk of experiencing HFH.

KW - All-cause mortality

KW - Comorbidity

KW - Heart failure

KW - Heart failure stages

KW - Population attributable risk

U2 - 10.1186/s12877-022-02875-1

DO - 10.1186/s12877-022-02875-1

M3 - Journal article

C2 - 35313808

AN - SCOPUS:85126739577

VL - 22

JO - B M C Geriatrics

JF - B M C Geriatrics

SN - 1471-2318

M1 - 230

ER -

ID: 309125686